Cargando…

Peptide HER2(776–788) represents a naturally processed broad MHC class II-restricted T cell epitope

HER2/neu-derived peptides inducing MHC class II-restricted CD4+ T helper lymphocyte (Th) responses, although critical for tumour rejection, are not thoroughly characterized. Here, we report the generation and characterization of CD4+ T cell clones specifically recognizing a HER-2/neu-derived peptide...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sotiriadou, R, Perez, S A, Gritzapis, A D, Sotiropoulou, P A, Echner, H, Heinzel, S, Mamalaki, A, Pawelec, G, Voelter, W, Baxevanis, C N, Papamichail, M
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2001
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363935/ https://www.ncbi.nlm.nih.gov/pubmed/11720440 http://dx.doi.org/10.1054/bjoc.2001.2089

Ejemplares similares

Cytotoxic T-cell precursor frequencies to HER-2 (369 – 377) in patients with HER-2/neu-positive epithelial tumours
por: Sotiropoulou, P A, et al.
Publicado: (2003)

Redirecting mouse T hybridoma against human breast and ovarian carcinomas: in vivo activity against HER-2/neu expressing cancer cells
por: Gritzapis, A D, et al.
Publicado: (2003)

Pooled peptides from HER-2/neu-overexpressing primary ovarian tumours induce CTL with potent antitumour responses in vitro and in vivo
por: Gritzapis, A D, et al.
Publicado: (2005)

Frequencies of an Immunogenic HER-2/neu Epitope of CD8+ T Lymphocytes Predict Favorable Clinical Outcomes in Prostate Cancer
por: Goulielmaki, Maria, et al.
Publicado: (2023)

Interleukin 1 beta synergises with interleukin 2 in the outgrowth of autologous tumour-reactive CD8+ effectors.
por: Baxevanis, C. N., et al.
Publicado: (1994)

The mannosylated extracellular domain of Her2/neu produced in P. pastoris induces protective antitumor immunity
por: Dimitriadis, Alexios, et al.
Publicado: (2009)

Prothymosin α and a prothymosin α-derived peptide enhance T(H)1-type immune responses against defined HER-2/neu epitopes
por: Ioannou, Kyriaki, et al.
Publicado: (2013)

Posters P788 - P999
Publicado: (2005)

Unraveling the role of preexisting immunity in prostate cancer patients vaccinated with a HER-2/neu hybrid peptide
por: Voutsas, Ioannis F., et al.
Publicado: (2016)

EGFR/HER2 inhibitor AEE788 increases ER-mediated transcription in HER2/ER-positive breast cancer cells but functions synergistically with endocrine therapy
por: Evans, A H, et al.
Publicado: (2010)

776 Quality Improvement in Prehospital Burn Care
por: Phillips, Frank, et al.
Publicado: (2022)

The broad spectrum of tyrosine kinase inhibitors. Treatment of a rare EGFR R776H mutation with Osimertinib: Case report
por: Cui, Joyce, et al.
Publicado: (2023)

HER2 G776S mutation promotes oncogenic potential in colorectal cancer cells when accompanied by loss of APC function
por: Mitani, Yosuke, et al.
Publicado: (2022)

Analytical comparability to evaluate impact of manufacturing changes of ARX788, an Anti-HER2 ADC in late-stage clinical development
por: Yu, Wayne, et al.
Publicado: (2023)

776 Importance of Adequate Nutrition Support in Severely Burned Patients
por: Stone, Amanda
Publicado: (2023)

776. Clinical Practice Gap Analysis of Physicians’ Understanding of Cytomegalovirus
por: Larkin, Amy, et al.
Publicado: (2023)

DRB1*11 allele expression and HER2 pre-existing immunity may predict benefit in breast cancer patients vaccinated with the HER2 modified AE37 peptide vaccine
por: Anastasopoulou, Eleftheria A, et al.
Publicado: (2015)

Epitopes associated with MHC restriction site of T cells. III. I-J epitope on MHC-restricted T helper cells
Publicado: (1987)

Phase 1 multicenter, dose-expansion study of ARX788 as monotherapy in HER2-positive advanced gastric and gastroesophageal junction adenocarcinoma
por: Zhang, Yang, et al.
Publicado: (2022)

A report on the clinical-pathological correlations of 788 gingival lesion
por: Gambino, Alessio, et al.
Publicado: (2017)

Specific HER2 Exon 20 Gly776 Deletion-Insertions in Non-Small Cell Lung Cancer: Structural Analysis and Sensitivity to HER2-Targeted Tyrosine Kinase Inhibitors
por: Yang, Guangjian, et al.
Publicado: (2022)

Human population and socioeconomic modulators of conservation performance in 788 Amazonian and Atlantic Forest reserves
por: de Marques, Ana Alice B., et al.
Publicado: (2016)

Growth of Ceria Nano-Islands on a Stepped Au(788) Surface
por: Ma, Teng, et al.
Publicado: (2015)

788 INCREASE IN ALCOHOLIC HEPATITIS CASES DURING COVID PANDEMIC IN THE US
por: Nair, Geethu G., et al.
Publicado: (2021)

Correction to Lancet Child Adolesc Health 2022; 6: 788–98
Publicado: (2023)

Correction to Lancet Child Adolesc Health 2022; 6: 788–98
Publicado: (2022)

New insights into the role of NK cells in cancer immunotherapy
por: Salagianni, Maria, et al.
Publicado: (2012)

Combination Immunotherapy in Prostate Cancer
por: Baxevanis, Constantin N., et al.
Publicado: (2022)

The importance of serine 776 in Ataxin-1 partner selection: A FRET Analysis
por: Menon, Rajesh P., et al.
Publicado: (2012)

run 1193 - p = 11.788 GeV/c - 8.5.1981, Verification and adjustment of the compensation for EM608/1 at p = 11.788 GeV/c
por: Swoboda, Detlef
Publicado: (1981)

Linking tumor with systemic environment in the search for novel biomarkers in breast cancer
por: Fortis, Sotirios P, et al.
Publicado: (2015)

Predicting MHC class I epitopes in large datasets
por: Roomp, Kirsten, et al.
Publicado: (2010)

Structural Properties of MHC Class II Ligands, Implications for the Prediction of MHC Class II Epitopes
por: Jørgensen, Kasper Winther, et al.
Publicado: (2010)

Spotlight on Mobocertinib (TAK-788) in NSCLC with EGFR Exon 20 Insertion Mutations
por: Zhang, Shannon S, et al.
Publicado: (2021)

Differential intratumoral distributions of CD8 and CD163 immune cells as prognostic biomarkers in breast cancer
por: Fortis, Sotirios P., et al.
Publicado: (2017)

Erratum to: Differential intratumoral distributions of CD8 and CD163 immune cells as prognostic biomarkers in breast cancer
por: Fortis, Sotirios P., et al.
Publicado: (2017)

Structural Allele-Specific Patterns Adopted by Epitopes in the MHC-I Cleft and Reconstruction of MHC:peptide Complexes to Cross-Reactivity Assessment
por: Antunes, Dinler A., et al.
Publicado: (2010)

The relation of age at menarche with age at natural menopause: a population study of 336 788 women in Norway
por: Bjelland, E K, et al.
Publicado: (2018)

Dendritic Cells Reveal a Broad Range of MHC Class I Epitopes for HIV-1 in Persons with Suppressed Viral Load on Antiretroviral Therapy
por: Huang, Xiao-Li, et al.
Publicado: (2010)

Impact of sex differences in co‐morbidities and medication adherence on outcome in 25 776 heart failure patients
por: Gürgöze, Muhammed T., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qp00du4ffv3dgdt3aof2pck16f